2008Shandong yiyaoRequires access

Effect of different dosage of nimodipine on cerebral vasospasm patients after subarachnoid hemorrhage

Lan Tan

Open publisher page 0 citations

Abstract

Objective To explore the optimal dosage of nimodipine on preventing and curing cerebral vasospasm after subarachnoid hemorrhage(SAH).Mehtods 60 patients with primarily SAH were treated with 4 defferent dosages of nimodipine(2,1,0.5,0.2 mg/h;SAH1,SAH2,SAH3,SAH4 group) respectively.At 1,3,7,10,14 d after SAH,the blood flow velocities(BFV) of middle cerebral artery(MCA) were monitored by transcranial Doppler(TCD).The endothelin-1(ET-1) and NO were observed.Results Compared with the SAH1 and SAH2 group,the level of ET-1 in plasma and CSF of SAH3 and SAH4 group increased significanthy,while the level of NO and Vm of MCA decreased.Conclusion 1 mg/h of nimodipine is the optimal dosage on preventing CVS.

About this research paper

What this paper is about

Objective To explore the optimal dosage of nimodipine on preventing and curing cerebral vasospasm after subarachnoid hemorrhage(SAH).Mehtods 60 patients with primarily SAH were treated with 4 defferent dosages of nimodipine(2,1,0.5,0.2 mg/h;SAH1,SAH2,SAH3,SAH4 group) respectively.At 1,3,7,10,14 d after SAH,the blood flow velocities(BFV) of middle cerebral artery(MCA) were monitored by transcranial Doppler(TCD).The endothelin-1(ET-1) and NO were observed.Results Compared with the SAH1 and SAH2 group,the level of ET-1 in plasma and CSF of SAH3 and SAH4 group increased significanthy,while the level of NO and Vm of MCA decreased.Conclusion 1 mg/h of nimodipine is the optimal dosage on preventing CVS.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the optimal dosage of nimodipine on preventing and curing cerebral vasospasm after subarachnoid hemorrhage(SAH).Mehtods 60 patients with primarily SAH were treated with 4 defferent dosages of nimodipine(2,1,0.5,0.2 mg/h;SAH1,SAH2,SAH3,SAH4 group) respectively.At 1,3,7,10,14 d after SAH,the blood flow velocities(BFV) of middle cerebral artery(MCA) were monitored by transcranial Doppler(TCD).The endothelin-1(ET-1) and NO were observed.Results Compared with the SAH1 and SAH2 group,the level of ET-1 in plasma and CSF of SAH3 and SAH4 group increased significanthy,while the level of NO and Vm of MCA decreased.Conclusion 1 mg/h of nimodipine is the optimal dosage on preventing CVS.

Key concepts: Nimodipine, Subarachnoid hemorrhage, Transcranial Doppler, Medicine, Anesthesia, Cerebral vasospasm, Dose, Vasospasm

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of different dosage of nimodipine on cerebral vasospasm patients after subarachnoid hemorrhage — Research Paper | ScholarLens